Condensed Consolidated Statements Of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Mar. 31, 2013		Mar. 31, 2012		Mar. 31, 2013		Mar. 31, 2012
Revenue:
Hardware	$ 64,523		$ 63,045		$ 195,527		$ 168,881
Software	36,821		37,577		106,346		105,402
Service	213,761		177,422		637,603		530,722
Total revenue	315,105	[1]	278,044	[1]	939,476	[1]	805,005	[1]
Cost of sales:
Hardware	41,514		40,187		127,867		106,988
Software	5,813		5,838		16,434		14,991
Service	102,290		79,484		304,308		233,754
Total cost of sales	149,617		125,509		448,609		355,733
Gross margin	165,488		152,535		490,867		449,272
Selling, general and administrative expenses	83,175		79,384		248,073		236,769
Research and development expenses	18,460		13,681		53,116		37,494
Depreciation and amortization	5,702		3,523		16,748		11,383
Total operating expenses	107,337		96,588		317,937		285,646
Income from operations	58,151		55,947		172,930		163,626
Non-operating income (expense):
Interest income	943		1,765		3,513		5,614
Interest expense	(24)		(160)		(290)		(429)
Other income, net	645		6		3,175		203
Total non-operating income, net	1,564		1,611		6,398		5,388
Income before taxes	59,715	[1]	57,558	[1]	179,328	[1]	169,014	[1]
Income tax provision	15,370		14,102		49,627		49,992
Net income	44,345		43,456		129,701		119,022
Less: Net income attributable to noncontrolling interest	(81)		(209)		(287)		(258)
Net income attributable to MICROS Systems, Inc.	44,264		43,247		129,414		118,764
Net income per share attributable to MICROS Systems, Inc. common shareholders:
Basic	$ 0.56		$ 0.54		$ 1.62		$ 1.48
Diluted	$ 0.55		$ 0.53		$ 1.59		$ 1.45
Weighted-average number of shares outstanding:
Basic	79,050		80,123		79,695		80,283
Diluted	80,502		82,008		81,272		82,127
The details of total other-than-temporary impairment losses ("OTTI") of long-term investments included in other non-operating income (expense):
Credit based OTTI recognized in non-operating income/expense					$ 600	[2]

[1] Amounts based on the location of the selling entity.

[2] See Note 3 "Financial Instruments and Fair Value Measurements" in Notes to Consolidated Financial Statements.